Northern Trust’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.59M | Buy |
339,025
+73,969
| +28% | +$1M | ﹤0.01% | 2506 |
|
|
2025
Q1 | $4.21M | Buy |
265,056
+18,943
| +8% | +$301K | ﹤0.01% | 2512 |
|
|
2024
Q4 | $3.03M | Buy |
246,113
+1,688
| +0.7% | +$20.8K | ﹤0.01% | 2791 |
|
|
2024
Q3 | $2.96M | Buy |
244,425
+76,624
| +46% | +$928K | ﹤0.01% | 2764 |
|
|
2024
Q2 | $1.96M | Buy |
167,801
+21,680
| +15% | +$254K | ﹤0.01% | 2908 |
|
|
2024
Q1 | $1.89M | Sell |
146,121
-3,659
| -2% | -$47.2K | ﹤0.01% | 2990 |
|
|
2023
Q4 | $1.29M | Buy |
149,780
+37,865
| +34% | +$326K | ﹤0.01% | 3217 |
|
|
2023
Q3 | $1.06M | Sell |
111,915
-599
| -0.5% | -$5.7K | ﹤0.01% | 3273 |
|
|
2023
Q2 | $1.92M | Buy |
112,514
+12,037
| +12% | +$205K | ﹤0.01% | 3030 |
|
|
2023
Q1 | $1.57M | Buy |
+100,477
| New | +$1.57M | ﹤0.01% | 3044 |
|